M3M
Asset Logo

M3 Mining Limited

🇦🇺 ASX

⛏️ MINING

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-23.58%
Annual Growth

3 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

M3 Mining Ltd. operates as a mining exploration company which focuses on unlocking copper and gold deposits. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-07-29. The firm is engaged in the exploration for mineral resources over two projects being the Victoria Bore Copper Project and the Edjudina Gold Project. The Victoria Bore Copper Project is located approximately 120 kilometers (km) south of the coast town of Onslow and 130 km southeast of Exmouth in Western Australia. The project contains granted exploration licenses, such as E08/3220, E08/3326, E08/3427, E08/3428, E08/3429, E08/3430, and E08/3431 centered on the historic Victoria Copper mine. The Edjudina Gold Project comprises granted exploration licenses, including E31/1140, E31/1141, E31/1168, E31/2113, E31/1249, E31/1258, E31/1265, E31/1344, E31/1345, E31/2131, and various other pending licenses. The Edjudina Project is located approximately 150 km northeast of the regional city of Kalgoorlie in Western Australia.

📈 Performance

Price History

-80.32%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.04

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in M3M

4

📊 Total Capital Earnings

$3K

🔃 Average investment frequency

30 weeks

💵 Average investment amount

$1,748

Last time a customer invested in M3M

70 days
M3M investor breakdown
💵 Income of investors

More than 200k

150k - 200k

14%

100k - 150k

14%

50k - 100k

29%

Less than 50k

43%
👶 Age of investors

18 - 25

25%

26 - 34

35 - 90

75%
🙋 Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in M3M also invest in...

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.

🙌 Performance (5Yr p.a)

159.59%

📊 Share price

$2.17 AUD

⛏️ MINING

Find Out More

Magnis Energy Technologies Ltd. is an integrated lithium-ion battery technology and materials company, which engages in the business of exploring, developing, and mining natural flake graphite. The company is headquartered in Sydney, New South Wales and currently employs 9 full-time employees. The company went IPO on 2005-10-25. Its subsidiary, Imperium3 New York Inc. (iM3NY), operates the Lithium-ion battery plant in Endicott, New York. iM3NY has commenced commercial production of Li ion cells and accelerating its ramp-up plans to produce 15,000 cells/day up to an annual production rate of 1.8 gigawatt hours with several binding offtakes already secured. Charge CCCV’s (C4V’s) proprietary Li-ion battery technology and discoveries are known for extending battery life, greater safety and charge performance. C4V’s also provides value chain solutions for Li ion battery manufacturing through cell design and engineering, cell fabrication process, qualification of raw materials supply chain and cell fabrication equipment supplier, blueprint of plants and engaging with engineering, procurement and construction (EPC) contractors.

🙌 Performance (5Yr p.a)

-9.37%

📊 Share price

$0.04 AUD

⛏️ MINING

Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.

🙌 Performance (5Yr p.a)

-4.99%

📊 Share price

$0.03 AUD

🧬 BIOTECHNOLOGY

Cogstate Ltd. is a global cognitive science company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-02-13. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.

🙌 Performance (5Yr p.a)

37.37%

📊 Share price

$1.09 AUD

🩺 HEALTH CARE

📈 HIGH PRICE GROWTH

Invion Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. Invion Limited is an Australia-based life science company. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. The company holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.

🙌 Performance (5Yr p.a)

380.00%

📊 Share price

$0.26 AUD

📦 LOGISTICS

Want more shares? Try these...

Macro Metals Ltd. engages in mineral exploration. The company is headquartered in Subiaco, Western Australia. Its Cane Bore Project is located approximately 141 Kilometers (km) by existing roads from Onslow Port, is adjacent to the Mineral Resources haulage corridor, and comprises a single granted exploration license 08/3078. Its Catho Well Project is located approximately 180 km via roads from Onslow Port and comprises a single granted exploration license 08/3087. The Goldsworthy East Iron Project is located over 100 km east of Port Headland via existing directly along strike from the BHP’s Mount Goldsworthy Mine. The West Pilbara Project is located over 120 km west-northwest of Paraburdoo, proximal to the sealed Nanutarra Road and is comprised of exploration license 08/1997. Its other iron projects include Turner, Deepdale, Bellary Springs, Mogul VMS, Wiluna West and Agbaja.

🙌 Performance (5Yr p.a)

-15.85%

📊 Share price

$0.01 AUD

⛏️ MINING

Miramar Resources Ltd. operates as an exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-10-22. The firm's projects include Eastern Goldfields Projects and Gascoyne Region Projects. The firm has three projects within the Gascoyne region of WA: Whaleshark, Bangemall and Chain Pool. The Whaleshark Project is located approximately 40 kilometers (kms) east of Onslow, WA, and consists of a single granted Exploration License, E08/3166. Its Bangemall Project covers approximately 2,190 square kilometers (km2). The Chain Pool Project consists of one Exploration License application, E08/3676. The company has three projects in the Eastern Goldfields with the potential for new gold discoveries within proximity to existing mining and/or processing operations. Its Eastern Goldfields Projects include Gidji JV Project, Glandore Project and Randalls Project.

📊 Share price

$0.00 AUD

⛏️ MINING

📊 Share price

$0.00 AUD
Compare
Add to watchlist